Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Carson

Showing results (21-30 of 272) with videos related to

Pageof 28
Sort By:
The Journal of Clinical Investigation|October 9, 2002
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cellsRobin Parihar, Julie Dierksheide, Yan Hu, et al.
Cellular Immunology|March 6, 2019
Emerging roles of and therapeutic strategies targeting BRD4 in cancerMary E White, Joelle M Fenger, William E Carson
Cancer Immunology, Immunotherapy : CII|March 11, 2008
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysisLisa M Thornton, Barbara L Andersen, William E Carson
Melanoma Research|July 19, 2018
Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanomaGonzalo N Olaverria Salavaggione, Megan C Duggan, William E Carson
American Journal of Translational Research|August 27, 2013
The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte responseZhenzhen Liu, Jianhua Yu, William E Carson, et al.
Surgical Oncology|August 28, 2016
MicroRNA dysregulation in melanomaNicholas Latchana, Akaansha Ganju, J Harrison Howard, et al.
Clinical Case Reports|December 20, 2018
Unusual recurrence of breast cancer in a BRCA-variant patient after fat graftingJohn P Skendelas, Clara Lee, Ann Mangino, et al.
Alternative Therapies in Health and Medicine|April 21, 2012
Review of complementary and alternative medicine and selected nutraceuticals: background for a pilot study on nutrigenomic intervention in patients with advanced cancerKimberly A Varker, Adam Ansel, Glen Aukerman, et al.
Cancer Research Communications|December 18, 2023
Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical TrialsEmily Schwarz, Brooke Benner, Lianbo Yu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2012
Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulationEric Luedke, Alena Cristina Jaime-Ramirez, Neela Bhave, et al.
Pageof 28

Showing results (21-30 of 272) with videos related to

Sort By:
Pageof 28
The Journal of Clinical Investigation|October 9, 2002
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cellsRobin Parihar, Julie Dierksheide, Yan Hu, et al.
Cellular Immunology|March 6, 2019
Emerging roles of and therapeutic strategies targeting BRD4 in cancerMary E White, Joelle M Fenger, William E Carson
Cancer Immunology, Immunotherapy : CII|March 11, 2008
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysisLisa M Thornton, Barbara L Andersen, William E Carson
Melanoma Research|July 19, 2018
Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanomaGonzalo N Olaverria Salavaggione, Megan C Duggan, William E Carson
American Journal of Translational Research|August 27, 2013
The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte responseZhenzhen Liu, Jianhua Yu, William E Carson, et al.
Surgical Oncology|August 28, 2016
MicroRNA dysregulation in melanomaNicholas Latchana, Akaansha Ganju, J Harrison Howard, et al.
Clinical Case Reports|December 20, 2018
Unusual recurrence of breast cancer in a BRCA-variant patient after fat graftingJohn P Skendelas, Clara Lee, Ann Mangino, et al.
Alternative Therapies in Health and Medicine|April 21, 2012
Review of complementary and alternative medicine and selected nutraceuticals: background for a pilot study on nutrigenomic intervention in patients with advanced cancerKimberly A Varker, Adam Ansel, Glen Aukerman, et al.
Cancer Research Communications|December 18, 2023
Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical TrialsEmily Schwarz, Brooke Benner, Lianbo Yu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2012
Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulationEric Luedke, Alena Cristina Jaime-Ramirez, Neela Bhave, et al.
Pageof 28